Clinical Trial Update: Effects of a 5:2 Diet on Weight Loss and Cardiovascular Risk Factors in Obesity [NA]

View source ↗

Summary

This completed clinical trial evaluated the effects of a 5:2 intermittent fasting diet on weight loss and cardiovascular risk factors in adults with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity

Snippet

Sponsor: Oslo University Hospital | Conditions: Obesity, CVD | NA | Status: COMPLETED